Maple Capital Management’s Colgate-Palmolive CL Stock Holding History

Maple Capital Management’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15.4M	Buy	180,417 +2,291	+1%	+$204K	1.03%	30
2025 Q4	$14.1M	Buy	178,126 +4,494	+3%	+$352K	0.89%	29
2025 Q3	$13.9M	Buy	173,632 +9,555	+6%	+$815K	0.91%	30
2025 Q2	$14.9M	Buy	164,077 +22,207	+16%	+$2.03M	1.02%	31
2025 Q1	$13.3M	Buy	141,870 +15,138	+12%	+$1.36M	1.03%	30
2024 Q4	$11.5M	Buy	126,732 +4,504	+4%	+$430K	0.85%	31
2024 Q3	$12.7M	Buy	122,228 +10,281	+9%	+$1.05M	0.97%	31
2024 Q2	$10.9M	Buy	+111,947	New	+$10.3M	0.88%	32
2014 Q3	–	Sell	-3,830	Closed	-$261K	–	123
2014 Q2	$261K	Hold	3,830	–	–	0.1%	108
2014 Q1	$248K	Hold	3,830	–	–	0.1%	113
2013 Q4	$250K	Sell	3,830 -60	-2%	-$3.84K	0.1%	116
2013 Q3	$231K	Hold	3,890	–	–	0.1%	113
2013 Q2	$223K	Buy	+3,890	New	+$231K	0.1%	110

Other funds holding CL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Maple Capital Management's CL Position: Q1 2026 in Review

Maple Capital Management increased its Colgate-Palmolive (CL) stake by 1.3% in Q1 2026, buying an estimated $204K and bringing the position to 180,417 shares worth $15.4M. The position accounts for 1.03% of the portfolio, ranked #30.

Maple Capital Management first reported a position in CL in Q2 2013 and has held it in 13 quarters since. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.

Maple Capital Management held 180,417 shares of Colgate-Palmolive worth $15.4M as of Q1 2026.
Maple Capital Management bought 2,291 Colgate-Palmolive shares in Q1 2026, an estimated $204K.
Colgate-Palmolive made up 1.03% of Maple Capital Management's portfolio in Q1 2026, its #30 holding.
Maple Capital Management first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 13 quarters since.
1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Maple Capital Management's 13F filing for Q1 2026, filed 8 May 2026.